CoChat

DNA fingerprinting of glioma cell lines and considerations on similarity measurements

Open access

The DOI matches its Crossref record; 28 of the 30 references it cites were found in a registry or an index.

Abstract

Glioma cell lines are an important tool for research in basic and translational neuro-oncology. Documentation of their genetic identity has become a requirement for scientific journals and grant applications to exclude cross-contamination and misidentification that lead to misinterpretation of results. Here, we report the standard 16 marker short tandem repeat (STR) DNA fingerprints for a panel of 39 widely used glioma cell lines as reference. Comparison of the fingerprints among themselves and with the large DSMZ database comprising 9 marker STRs for 2278 cell lines uncovered 3 misidentified cell lines and confirmed previously known cross-contaminations. Furthermore, 2 glioma cell lines exhibited identity scores of 0.8, which is proposed as the cutoff for detecting cross-contamination. Additional characteristics, comprising lack of a B-raf mutation in one line and a similarity score of 1 with the original tumor tissue in the other, excluded a cross-contamination. Subsequent simulation procedures suggested that, when using DNA fingerprints comprising only 9 STR markers, the commonly used similarity score of 0.8 is not sufficiently stringent to unambiguously differentiate the origin. DNA fingerprints are confounded by frequent genetic alterations in cancer cell lines, particularly loss of heterozygosity, that reduce the informativeness of STR markers and, thereby, the overall power for distinction. The similarity score depends on the number of markers measured; thus, more markers or additional cell line characteristics, such as information on specific mutations, may be necessary to clarify the origin.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/neuonc/nos072

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 6

  1. 1999, TISSUE CULTURE RESEARCH COMMUNICATIONS, 18, 329
  2. 1999, TISS CULT RES COMMUN, 18, 329
  3. Jones, 2001, Cancer Research, 61, 4978
  4. 1948, BIOL SKR, 5, 1
  5. Alonso, 2001, Cancer Research, 61, 2124
  6. Ozawa, 1998, In Vivo, 12, 369

Cited by

See all 62

Metadata

Authors
Bady, P., Diserens, A.-C., Castella, V., Kalt, S., Heinimann, K., Hamou, M.-F., Delorenzi, M., & Hegi, M. E.
Affiliations
Centre Hospitalier Universitaire Vaudois (CH)
Corresponding author
Hegi, M. E.
Venue
Neuro-Oncology
Published
2012-05-08
Volume
14
Issue
6
Pages
701-711
ISSN
  • 1522-8517 (ISSN-L)
  • 1523-5866
OpenAlex
W2167080944
Cited by
57
References
30
Citations by year
2026: 3 · 2025: 1 · 2024: 1 · 2023: 5 · 2022: 2 · 2021: 5 · 2020: 6 · 2019: 5 · 2018: 10 · 2017: 3 · 2016: 4 · 2015: 4 · 2014: 1 · 2013: 4 · 2012: 3
FWCI
1.73
Type
journal article
Language
en
Open access
Locations
  • Neuro-Oncology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
Funders
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Topics
  • Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic diversity and population structure
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Identification and Quantification in Food
Keywords
glioma cell lines, DNA fingerprinting, microsatellite markers, cell line cross-contamination, cell line misidentification, similarity scores, loss of heterozygosity, BRAF mutation
MeSH terms
Brain Neoplasms, DNA, Neoplasm, Glioma, Humans, Tumor Cells, Cultured, Biomarkers, Tumor, Polymerase Chain Reaction, DNA Fingerprinting, Microsatellite Repeats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.